ライフサイエンスコーパス: panel

1 , 2017, we enrolled 30 participants (six per panel).

2 targeted next generation sequencing (48-gene panel).

3 y was atypical for genes within the targeted panel.

4 epitope was identified and removed from the panel.

5 and evaluated using a trained adult sensory panel.

6 ples in the 1000 Genomes Project phase three panel.

7 ns with a negative genetic retinal dystrophy panel.

8 r next generation sequencing with a myopathy panel.

9 f amino acid characters in the sequence logo panel.

10 .2% Setser80, 87.9% Seldin panel, 71.4% Kidd panel.

11 ative targets that are unique to the BCID-GP Panel.

12 ainst a majority of the viruses in the H2 HA panel.

13 case of multiple targets in the same digital panel.

14 = 780) were first sequenced using a 264 gene panel.

15 aint odour were assessed by a trained expert panel.

16 xamined multiple lots of a human 51-cytokine panel.

17 additional references selected by the Expert Panel.

18 riability in expression across the cell line panel.

19 n among subjects at risk, using multi-marker panels.

20 lity and can be evaluated by trained tasting panels.

21 immediate postoperative surrogate pain score panels.

22 cted a meta-analysis of the two case-control panels.

23 riments and across non-overlapping cell line panels.

24 e and standard DNA by WES and five different panels.

25 fers from their activity against pseudovirus panels.

26 Results: In the tumor panel, (18)F-AraG revealed strikingly different uptake p

27 ion accuracies: 93.2% Setser80, 87.9% Seldin panel, 71.4% Kidd panel.

28 GB Kantar Fast-Moving Consumer Goods (FMCG) panel, a large representative household purchase panel o

29 However, the Expert Panel acknowledges that there are limited data on endocr

30 ucted to assess the utility of the T2Candida panel across an academic health center and identify pote

31 The panel also provides general guidelines with relevance fo

32 ASCO convened an Expert Panel and conducted a systematic review of the literatur

33 A total of 433 paired T2Candida panel and myco/f lytic blood cultures were identified.

34 w was conducted on patients with a T2Candida panel and mycolytic/fungal (myco/f lytic) blood culture

35 Large germline panels and somatic testing were recommended for metastat

36 imaging, newborn screening, routine testing panels, and antibiotic sensitivity testing all lead to d

37 wborn screening programs, routine laboratory panels, and antibiotic sensitivity testing, and that the

38 ping microarrays, large imputation reference panels, and functional annotation approaches.

39 rge-area (> 8 cm x 4 cm without tiling) flat panel applications, such as amorphous selenium (a-Se), h

40 4A the Gapdh panels are incorrect.

41 tion with an appropriate targeted sequencing panel as a cost-effective diagnostic test, especially in

42 Clinicians should use this panel as an adjunct to blood cultures when making a defi

43 the way towards applications in large multi-panel assays.

44 m peripheral blood with a customized 21-gene panel at a median coverage of 6179X.

45 isolate (20 unique isolates, duplicated) EQA panel at three time points.

46 autoantibodies in arrhythmogenesis, a large-panel autoantibody screening was performed in patients w

47 e strengths and limitations of existing gene-panel based methods.

48 y the MDWG to identify a broadly useful gene panel based on whole transcriptome technology.

49 es revealed that some members of the protein panel can distinguish aggressive from indolent cancers.

50 Our results indicate the Setser80 SNP panel can reliably classify BGA for individuals of presu

51 ularly when using next-generation sequencing panels, can be nuanced.

52 such as the CDC 2019-nCoV RT-PCR Diagnostic Panel, Cellex's qSARS-CoV-2 IgG/IgM Rapid Test, and poin

53 he multiplex biosensor system with on-demand panel composition can be used fully autonomously in clin

54 ted," and "non-descript" as adjudicated by a panel comprised of a transplant surgeon, a hepatologist,

55 An Expert Panel conducted a targeted systematic literature review

56 A panel consisting of C1RL, GP1BA, VTNC, and ZA2G demonstr

57 The Expert Panel continues to endorse the remaining recommendations

58 The Expert Panel continues to recommend ER testing of invasive brea

59 n 4 of the 141 clinical samples, the BCID-FP panel correctly identified an additional Candida species

60 Trained sensory panel could not discriminate treatment effects on wine f

61 Algorithm-derived panel decisions showed high sensitivity 94% (95%CI 68, 1

62 power increase of ~5% and decrease of solar panel degradation by +0.3%/year.

63 The PN panel demonstrated a combined 96.2% positive percent agr

64 nt performance without abandoning current PV panel designs, allowing for practical adoption into the

65 riant persistence identified on clinical NGS panels, despite a change in disease state.

66 The TBP panel detected three coinfections, with two of Babesia m

67 he Drosophila melanogaster Genetic Reference Panel (DGRP) contain at least one P-element insertion in

68 has emerged, including multiplexed molecular panels directly applicable to blood and blood culture sp

69 -papers (moderators, presenters at symposia, panel discussions, workshops/instructional courses) were

70 e easy to stylize and incorporate into multi-panel figures.

71 pid, and accurate sample-to-answer multiplex panel for the detection of the most common viral and bac

72 analysis proposed a mid-trimester biomarker panel for the prediction of PE with five metabolites (SM

73 conventionally prepared frozen reference BMD panels for a number of drugs, including aztreonam-avibac

74 Such panels for breast cancer are lacking.

75 atives or tissue sampling, selection of gene panels for routine diagnosis should take this informatio

76 The panel generated a checklist of recommendations regarding

77 red pre-invasive and invasive components for panel-genomic sequencing and recognize three evolutionar

78 Therefore, the panel has discussed, step by step, the possible differen

79 rlier after introduction of the FilmArray GI panel (hospital day 1 vs. 2, p < 0.0001).

80 GWA with the whole panel identified 29 QTL for height and disease resistanc

81 Gene ontology analysis of the gene panel identified multiple biological roles ranging from

82 g the National Cancer Institute 60 cell line panel identified the MT1E gene to be overexpressed in ce

83 Viral targets were identified by the PN panel in 17.7% of specimens tested, of which 39.1% were

84 An exome-based diagnostic panel in an infant with epilepsy revealed a previously u

85 asma CA19-9 enhanced the performance of this panel in discriminating PDAC I-II patients from controls

86 supplement the currently used serum hormone panel in the diagnosis of various subtypes of pituitary

87 sd; N = 7) was determined for the different panels in a tumor paired normal setting for WES.

88 World Evidence Longitudinal Patient Database panels in France.

89 e trait loci (eQTLs) from external reference panels in relevant tissues.

90 recommendations from the convened consensus panel included (1) establishment of infrastructure for m

91 on (95% CI 0.888-0.984) datasets for the new panel including REG1B.

92 We found that the T2Candida panel is a highly specific diagnostic tool; however, the

93 lture Identification Gram-Positive (BCID-GP) Panel is a multiplex nucleic acid amplification assay ba

94 This Banff Human Organ Transplant (B-HOT) panel is the culmination of previous work by the MDWG to

95 usion of ferritin into the sepsis laboratory panel is warranted.

96 far only approaches based at the individual panel level have been investigated, while the more compl

97 The panel made 26 recommendations for new research and metho

98 The panel made a weak recommendation for systemic antibacter

99 io Health (Cancer Care Ontario) NSCLC Expert Panel made updated recommendations based on a systematic

100 owever, ancestry- or race-specific reference panels may be needed to draw correct inference in ancest

101 ed responses from prior surveys were sent to panel members.

102 The panel methodologist (V.K.A.) assigned a level of evidenc

103 A panel methodologist then assigned a level of evidence ra

104 assigned a quality-of-evidence rating by the panel methodologist.

105 s were rated for strength of evidence by the panel methodologist.

106 e assigned a level of evidence rating by the panel methodologist.

107 ere examined using longitudinal cross-lagged panel modeling.

108 Committee (DODAC) and the Ophthalmic Devices Panel (ODP) of the Food and Drug Administration (FDA) to

109 From a panel of 10 cytokines, the pro-inflammatory cytokine IL-

110 lectivity for the GRK2 subfamily in a kinome panel of 104 kinases.

111 on of sRNA variation and inheritance among a panel of 108 maize (Zea mays) samples spanning five tiss

112 I ligands representing an unexpectedly broad panel of 123 HCMV antigens.

113 A panel of 143 biomarkers was measured by using Luminex te

114 A volunteer panel of 15 experts in HIV research and patient care con

115 cell, high-content imaging screens against a panel of 15 reporter cell lines, which expressed a diver

116 ant and susceptible lines in a new diversity panel of 159 wheat germplasm.

117 sequence variation in three Sub1 genes in a panel of 179 rice genotypes and its association with sub

118 from 1/1/1985 to 11/9/2018 was reviewed by a panel of 19 experts in thyroid disorders representing mu

119 cular characterization and drug testing in a panel of 20 prostate cancer cell lines.

120 An expert panel of 24 members, including pulmonologists (n = 17),

121 d BRSK2 that were identified in the original panel of 260 kinases as well as surfaced other kinases t

122 ew of cytologic specimens was performed by a panel of 3 expert cytopathologists.

123 ation sequencing and tested against a custom panel of 347 cancer genes.Measurements and Main Results:

124 Common genetic variants in a diagnostic gene panel of 396 autosomal intellectual disability genes wer

125 over 100-fold selectivity to NTMT1/2 among a panel of 41 MTs, indicating its potential to achieve hig

126 Furthermore, we fingerprinted a large panel of 4143 lines for the 2NS translocation that provi

127 n = 21) were tested for reactivity against a panel of 44 non-HLA autoantigens.

128 revious studies, we genotyped an association panel of 508 inbred lines genotyped with a total of ~550

129 genome-wide association study (GWAS) using a panel of 5130 clones developed at the International Inst

130 f response to EZH2 inhibitors, we screened a panel of 53 melanoma cell lines for drug sensitivity.

131 In addition, we characterize a panel of 62 CF-causing mutations.

132 We present application of the utility to a panel of 62 cytokines in a sample of human patients diag

133 onal effects in full-length BTK induced by a panel of active site inhibitors, including large-scale s

134 RPS18, ATPase and GST, were analyzed using a panel of analytical tools, including geNorm, NormFinder,

135 an "epitope mining" phase, in which a second panel of antibodies is designed to specifically target t

136 After testing a panel of antibodies with our method, we identified 16 an

137 We screened a panel of anticomplement protein autoantibodies, carried

138 han 200 cytoprotective proteins, including a panel of antioxidant enzymes.

139 ormed a laboratory evolution experiment on a panel of artificial hybrids to measure TE accumulation i

140 other parameter in our in vivo and in vitro panel of assessment.

141 we mapped transcriptome data from a diverse panel of B. juncea accessions.

142 scores as the prior knowledge to assemble a panel of biomarkers.

143 lar, by scoring germination across a diverse panel of Brassica napus varieties, SeedGerm implicates a

144 activates both the ERK and JNK pathways in a panel of cancer cell lines.

145 d tested for in vitro cytotoxicity against a panel of cancer cell lines.

146 Here, we screened a panel of Cas9 nucleases and identified a small Cas9 orth

147 By using an isogenic panel of cell lines derived from MDA-MB-231 breast cance

148 The MAbs' reactivities to a panel of class 5 adhesins in enzyme-linked immunosorbent

149 f commercially available compounds against a panel of clinically relevant BLs: class A CTX-M-15 and K

150 n system (LIPS) for antibody profiling and a panel of conserved EEHV recombinant proteins and protein

151 and 55 years and were above the median of a panel of controls who had donated convalescent serum.

152 lizing titres reached 1.9-4.6-fold that of a panel of COVID-19 convalescent human sera, which were ob

153 JH112 exhibits high selectivity over a panel of different GPCRs, is able to cross the blood-bra

154 of concern, thus making it plausible that a panel of eight diastereomeric chagosensine-like compound

155 vestigated prion strain diversity in a large panel of European goats by a novel experimental approach

156 Thus, we selected a panel of exosome proteins for knock down, and confirmed

157 , conceptual criteria proposed by an Italian panel of experts are widely used for this purpose.

158 ed SWCNTs with different sequences against a panel of fat-soluble vitamins in canola oil, identifying

159 s a unique approach by directly monitoring a panel of five cytokine biomarkers (IL-6, IL-8, IL-10, TR

160 erefore examined antitumor efficacy across a panel of five PI3K inhibitors with distinctive isoform-s

161 l, a large representative household purchase panel of food and beverages brought home, and restricted

162 o complement-independent neutralization by a panel of gB monoclonal antibodies than a wild-type gC re

163 Tested against a panel of GBM cell lines in vitro, paclitaxel was found t

164 ese findings are a step towards developing a panel of genetic markers assessing risk of infection-rel

165 erformed genome-wide CRISPR screens across a panel of genetically diverse mouse cancer cell lines tha

166 Results were evaluated against a panel of ground truth compounds and compared to other cl

167 F0045 is enantioselective against a panel of group 1 HAs and F0045(S) exhibits in vitro neut

168 tination inhibition (HAI) activity against a panel of H1N1 influenza viruses.

169 Diagnostic efficacy is evaluated by a panel of hematologists performing a blind analysis of bl

170 There is a panel of highly complex RNA structures in the UTRs with

171 imeric antigen receptor (CAR) haNKs killed a panel of human and murine head and neck cancer cells at

172 We compared across an isogenic panel of human breast cancer cells derived from MDA-MB-2

173 f a large (384 enzymes) and sequence-diverse panel of imine reductases available for screening.

174 xy vitamin D, folate, and vitamin B12; and a panel of immune response markers.

175 Comparing genomic features among a large panel of individuals across the same species is consider

176 ors on the DNA methylation landscape using a panel of knockout human embryonic stem cell (ESC) lines.

177 imaging of a model tumor marker (EGFR) on a panel of living cancer cells.

178 orting this, modulation of SASH1 levels in a panel of lung cancer cell lines mediated changes in cell

179 iety of Clinical Oncology convened an Expert Panel of medical oncology, surgery, radiation oncology,

180 We investigated a wide omics panel of metabolites and lipids related to DR in type 1

181 ons that were genetically characterized by a panel of microsatellite loci for P. falciparum (26) and

182 We previously isolated a large panel of monoclonal antibodies (mAbs) from B cells of a

183 nt, oncogenic HPV genotypes by using a large panel of monoclonal antibodies (MAbs) raised against the

184 With a panel of more than 100 well-characterized clinical sampl

185 a scientific workshop with an international panel of more than 80 experts.

186 r mammalian development, profiling a diverse panel of mouse tissues at 8 developmental stages from 10

187 Here, using a panel of newly developed peptide-exchangeable peptide/HL

188 augmented database was evaluated using (i) a panel of nine control strains and (ii) 288 human-source

189 In this study, we designed a panel of novel immunogens that 1) preferentially expose

190 g specific response profiles to a diagnostic panel of odorants and identified three paralogous recept

191 atic approach that provided an unprecedented panel of oligosaccharides composed of the inner-core of

192 visualizing cellular PLD activity, yielded a panel of optoPLDs whose range of catalytic activities en

193 s and excellent reaction efficiencies with a panel of oxaziridines.

194 orking group, consisting of an international panel of paediatric and adult neuro-oncologists, clinici

195 orking group, consisting of an international panel of paediatric and adult neuro-oncologists, clinici

196 appaB subunits, RelA and c-Rel, induced by a panel of pathogen-derived stimuli in immune and nonimmun

197 A panel of patient-derived ovarian cancer xenografts (PDX)

198 Finally, experiments with a panel of patient-derived Vif isolates indicated that PPP

199 We aimed to characterize a comprehensive panel of plasma eicosanoids longitudinally across gestat

200 We isolate and characterize a panel of plasmablast-derived monoclonal antibodies from

201 cy and consequently, we have characterised a panel of preclinical models for their SSTR2 expression,

202 ined immunity provides protection in a large panel of preclinical models of infections.

203 ncorporated the evaluation of compounds in a panel of primary ADPKD and normal human kidney (NHK) epi

204 G1 phase and causes growth retardation in a panel of prostate cancer cells.

205 cute pruritus was induced by a comprehensive panel of pruritogens (C48/80, endothelin, 5-HT, chloroqu

206 Recommendations were formulated by a panel of pulmonary and sleep physicians, respiratory the

207 y consisting of a cell-based biosensor (CBB) panel of pure bacterial strains, a fluorescent dye, and

208 A panel of radiochemicals has enabled in vivo positron emi

209 employed to evaluate associations between a panel of six MBD parameters and renal outcomes.

210 lacking both pilins are resistant to a broad panel of SSVs as well as a panel of unrelated S. islandi

211 mechanisms have been defined using a limited panel of substrates that aberrantly occupy the channel.

212 e examined interoceptive processing across a panel of tasks: breath-hold challenge, cold-pressor chal

213 Despite the limited panel of test antigens, clones of antigen-responsive CD4

214 formation data to identify target genes of a panel of TFs.

215 Moreover, a subset panel of the 12 most powerful SNPs is sufficient to sepa

216 trategy, we first evaluated the ability of a panel of uncharacterized anti-gH/gL MAbs to block bindin

217 istant to a broad panel of SSVs as well as a panel of unrelated S. islandicus rod-shaped viruses (SIR

218 self-association, and adhesion modality in a panel of variants of the Car9 silica-binding peptide (DS

219 In this study, we compare two panels of glycan-adapted IgG1-Fc mutants expressed in ei

220 The ability to generate large panels of peptides and subsequently large bodies of pept

221 ng alternative method when seeking to assess panels of protein biomarkers with a view to providing pr

222 that have been profiled on near-kinome-wide panels of protein kinases.

223 anges and for 21st-century Intergovernmental Panel on Climate Change (IPCC) projections that suggest

224 sed by the United Nation's Intergovernmental Panel on Climate Change, most often assess POC (particul

225 logistic regression (MLR), we compared the 3 panels on the combined dataset and found overall MLR cla

226 Whole exome sequencing, a cancer gene panel, or both were carried out.

227 ge with current PV is preserving the optimal panel orientation angle with respect to the sun for effi

228 Blood pressure, lipid panel, oxidized (GSH) & reduced glutathione (GSSG) were

229 e FilmArray meningitis/encephalitis (FA-M/E) panel permits rapid, simultaneous pathogen detection.

230 This open-label, consecutive-panel, phase 1b trial was done at Charite Research Organ

231 tations, and public comments, an independent panel prepared a draft report that was posted for public

232 These panels provide genetic resolution for variant discovery

233 ion, low certainty).Conclusions: This expert panel provides evidence-based recommendations addressing

234 The QIAstat-Dx Respiratory Panel (QIAstat-Dx RP) is a multiplex in vitro diagnostic

235 d controls (e.g., AssayChex Process, Control Panel; Radix Biosolutions, Georgetown, TX) can determine

236 Over three iterative rounds, the expert panel reached consensus on a critical care content outli

237 r II >99%, complement-dependent cytotoxicity panel reactive antibody [CDC PRA+], C1q+) heart transpla

238 Four highly sensitized (calculated panel reactive antibody [cPRA] class I and/or II >99%, c

239 Small reductions in calculated panel-reactive antibody (cPRA) are associated with incre

240 The panel recommends a vendor-neutral rule of four for inter

241 This expert panel report reviews the current understanding of pain i

242 ustment in 70.7% of patients based on the PN panel result, including discontinuation or de-escalation

243 Positive ME panel results were confirmed before reporting through co

244 capable of neutralizing 49% of a 208-strain panel, revealed a V2 apex mode of recognition like that

245 The Expert Panel reviewed abstracts from the literature review and

246 e, namely, the BioFire FilmArray respiratory panel (RP), the Meridian Alethia Mycoplasma Direct, the

247 o the established ePlex Respiratory Pathogen Panel (RPP) assay, for which we used 287 respiratory sam

248 rect, the GenMark ePlex respiratory pathogen panel (RPP), the Luminex NxTAG RPP, the ELITech ELITe In

249 differed in age (P < .02) and EoE diagnostic panel score (P < 1.08E-30) but not in eosinophil levels.

250 A 309-clone diversity panel (SDP1) was developed that captured the genetic div

251 e organic compound (VOCs) fingerprint and by panel sensory profiling (SENS).

252 the genomic landscape of sRCC using targeted panel sequencing including patients with microdissected

253 1b, therefore the Gapdh panels should be the same in both figures.

254 Sensory analysis conducted by a trained panel showed that for both wine types the high GSP treat

255 evidence of an association between increased panel size and provider burnout.

256 commendations about the optimal primary care panel size for achieving beneficial health outcomes.

257 d moderate-certainty evidence that adjusting panel size for case mix and adding clinical conditions t

258 No studies assessed the effect of panel size on safety, efficiency, or equity.

259 vided low-certainty evidence that increasing panel size was associated with variable effects on timel

260 aintained by a majority of antibodies in the panel, suggesting that this drift may not lead to escape

261 in 2010-2017, using the Medical Expenditure Panel Survey.

262 THe HRSA held a 1-day Technical Expert Panel (TEP) to explore how RWHAP can best respond to the

263 Outcomes included the ME panel test utilization rate, negative predictive value o

264 ults of a 28-gene next-generation sequencing panel test.

265 ary tumors is made using serum based hormone panel test.

266 cceptability we conducted both human sensory panel testing and chemical analyses on a range of STPs.

267 and CSF cryptococcal antigen or by repeat ME panel testing.

268 nvestigated the ability of a DNA methylation panel (the S5 classifier) to discriminate between outcom

269 ementia is a next-generation sequencing gene panel, though some conditions necessitate specific types

270 We applied a validated NGS dementia panel to 3241 patients with dementia and healthy aged co

271 ASCO convened an Expert Panel to conduct a systematic review of published phase

272 A with REG1B enhanced the performance of the panel to detect resectable PDAC.

273 rganization (WHO) assembled an international panel to develop animal models for COVID-19 to accelerat

274 hort confirmed the ability of this biomarker panel to distinguish PE from non-PE, with comparable dis

275 We used the TruSight Cardio sequencing panel to evaluate the burden of rare variants in 56 puta

276 d the investigational-use-only (IUO) BCID-GP Panel to other methods of identification of 20 Gram-posi

277 Society of America (IDSA) convened an expert panel to perform a systematic review of the coronavirus

278 ASCO convened an Expert Panel to review the evidence and formulate recommendatio

279 ly compared the performance of the molecular panel to routine quantitative bacterial culture methods

280 luating HNT stress impact on large diversity panels to enhance HNT stress tolerance across field crop

281 trains from the Drosophila Genetic Reference Panel) to search for natural genetic variants that regul

282 We grew a sunflower diversity panel under control and salt-stressed conditions and mea

283 The guideline panel updated the systematic literature review, develope

284 leukocyte antigen (HLA) haplotype reference panel used for calculation of the CPRA by the United Net

285 QIAstat-Dx Respiratory Panel V2 (RP) is a novel molecular-method-based syndromi

286 of guidelines addressing the use of targeted panels versus whole-exome sequencing (WES).

287 Hu-NSG mice studies, the FAST-DOSE biomarker panel was able to generate delivered dose estimates at d

288 e, whereas in the NHP studies, the biomarker panel was able to successfully classify samples by dose

289 The panel was convened by video teleconference to discuss an

290 An Expert Panel was convened with members from ASCO and the Societ

291 An Expert Panel was formed, and a systematic review of the literat

292 ts viewed comics sequences in which a target panel was highly predictable ("high cloze"), less predic

293 From this panel, we identified 355 050 single nucleotide polymorph

294 Recognizing these limitations, the IDSA panel weighed available diagnostic evidence and recommen

295 were formulated and graded after the expert panel weighed desirable and undesirable consequences, ce

296 The most preferred kefirs by the sensorial panel were KSJ and KPJ, followed by KBMJ and KBCJ.

297 mance characteristics of digitally dispensed panels were equivalent to those of conventionally prepar

298 ing complete blood count and basic metabolic panels, were normal.

299 orldpanel, a commercial household purchasing panel with approximately 30,000 British members that inc

300 An ASCO multidisciplinary Expert Panel, with representatives from the European Associatio